指南与共识自身炎症与 IgG4 相关病

成人起病Still病的治疗:专家基于证据和共识的推荐

Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts.
指南 / 共识 · Rheumatology (Oxford) · 2024-01-01

该研究通过三轮Delphi专家小组(18名风湿科、内科和儿科专家)就成人起病Still病的诊断与治疗策略达成共识,共识阈值为80%,最终形成29条共识声明,涵盖诊断与检查、应答与缓解定义、治疗、甲氨蝶呤使用及减量方案,并据此提出治疗算法。

要点

  • 共识强调减少糖皮质激素使用以避免副作用,并优先选择生物制剂而非传统治疗。
  • IL-1和IL-6阻断剂在成人起病Still病治疗中的作用被认为重要。
  • 共达成29条共识声明,涵盖诊断、应答与缓解定义、治疗及甲氨蝶呤使用与减量。

核心结论

  • 该Delphi专家小组就成人起病Still病的诊断和治疗推荐达成高度共识,可作为治疗指南的基础。

研究设计与样本

  • Delphi专家小组由18名成人起病Still病专家组成,包括风湿科医生、内科医生和儿科医生。
  • Delphi过程包括三轮:前两轮在线完成问题与声明列表,第三轮在虚拟会议上讨论最终声明并进行最终投票。
  • 共识阈值设定为80%。
  • 进行了两项针对性文献检索以确定共识声明的证据水平。

主要发现

  • 共就29条声明达成共识,涉及诊断与诊断检查、应答与缓解定义、治疗、甲氨蝶呤使用及治疗减量。
  • 专家小组同意减少糖皮质激素使用以避免副作用,并优先选择生物制剂而非传统治疗。
  • IL-1和IL-6阻断剂在成人起病Still病治疗中的作用被认为重要。

关键数值与推荐

  • 共识阈值设定为80%。
  • 共达成29条共识声明。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Adult-onset Still's disease (AOSD) is a rare condition characterized by fevers, rash, and arthralgia/arthritis; most doctors treating AOSD in the Netherlands treat <5 patients per year. Currently, there is no internationally accepted treatment guideline for AOSD. The objectives of this study were to conduct a Delphi panel aimed at reaching consensus about diagnostic and treatment strategies for patients with AOSD and to use the outcomes as a basis for a treatment algorithm. METHODS: The Delphi panel brought together 18 AOSD experts: rheumatologists, internists and paediatricians. The Delphi process consisted of three rounds. In the first two rounds, online lists of questions and statements were completed. In the third round, final statements were discussed during a virtual meeting and a final vote took place. Consensus threshold was set at 80%. Two targeted literature searches were performed identifying the level of evidence of the consensus-based statements. RESULTS: Consensus was reached on 29 statements, including statements related to diagnosis and diagnostic tests, definition of response and remission, the therapy, the use of methotrexate and tapering of treatment. The panel consented on reduction of the use of glucocorticoids to avoid side effects, and preferred the use of biologics over conventional treatment. The role of IL-1 and IL-6 blocking agents was considered important in the treatment of AOSD. CONCLUSION: In this Delphi panel, a high level of consensus was achieved on recommendations for diagnosis and therapy of AOSD that can serve as a basis for a treatment guideline.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Leavis HL, van Daele PLA, Mulders-Manders C, et al. Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts. Rheumatology (Oxford). 2024. PMID: 37669122. doi:10.1093/rheumatology/kead461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。